Clinical Trial Detail

NCT ID NCT02603419
Title Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Pfizer
Indications

Hodgkin's lymphoma

Therapies

Avelumab

Age Groups: adult

No variant requirements are available.